You are viewing an incomplete version of our website. Please click to reload the website as full version.

B-Cell CLL/lymphoma 9-Like (BCL9L) ELISA Kits

BCL9 is associated with B-cell acute lymphoblastic leukemia. Additionally we are shipping B-Cell CLL/lymphoma 9-Like Antibodies (34) and B-Cell CLL/lymphoma 9-Like Proteins (3) and many more products for this protein.

list all ELISA KIts Gene Name GeneID UniProt
Anti-Mouse BCL9L BCL9L 77578 Q9D219
BCL9L 607 O00512
Anti-Rat BCL9L BCL9L 300673  
How to order from antibodies-online
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Order online

Top B-Cell CLL/lymphoma 9-Like ELISA Kits at

Showing 1 out of 2 products:

Catalog No. Reactivity Sensitivity Range Quantity Supplier Delivery Price Details
Human 0.124 ng/mL 0.31-20 ng/mL 96 Tests Log in to see 9 to 11 Days

More ELISA Kits for B-Cell CLL/lymphoma 9-Like Interaction Partners

Mouse (Murine) B-Cell CLL/lymphoma 9-Like (BCL9L) interaction partners

  1. Study demonstrates that the Golgi resident protein GM130 (show GOLGA2 ELISA Kits) activates the spindle assembly factor TPX2 (show DAZL ELISA Kits) to nucleate microtubules around the Golgi and further captures them to couple mitotic membranes to the spindle.

  2. BCL9-2 induces ER positive breast cancers in vivo, regulates ER expression by a novel ss-catenin independent mechanism in breast cancer cells.

  3. Pax6 (show PAX6 ELISA Kits), the master regulator of eye development, directly activates Bcl9 (show BCL9 ELISA Kits)/9l transcription.

  4. Data show that the GCM1/syncytin-B pathway is significantly downregulated in the placenta of BCL9L-deficient mice and that the fusion and differentiation of ST-II cells are blocked.

  5. BCL9-2 promotes early phases of intestinal tumor progression in humans and in transgenic mice. BCL9-2 increases the expression of a subset of canonical Wnt (show WNT2 ELISA Kits) target genes but also regulates genes that are required for early stages of tumor progression.

  6. These results suggest a critical role of BCL9 (show BCL9 ELISA Kits)/9-2 in the Wnt (show WNT2 ELISA Kits)-mediated regulation of adult, as opposed to embryonic, myogenic progenitors.

  7. We demonstrated that nuclear B9L expression was closely associated with the high nuclear grade cancer phenotype and the expression of ErbB2/HER-2 (show ERBB2 ELISA Kits) in breast cancers.

Human B-Cell CLL/lymphoma 9-Like (BCL9L) interaction partners

  1. findings indicate that BCL9 (show BCL9 ELISA Kits) most likely does not harbor a common genetic variant that can increase the risk for schizophrenia in the Japanese population

  2. BCL9 (show BCL9 ELISA Kits)/9L-beta-catenin (show CTNNB1 ELISA Kits) Signaling is Associated With Poor Outcome in Colorectal Cancer

  3. BCL9 (show BCL9 ELISA Kits) is a molecular driver of DCIS invasive progression.

  4. PCDH10 (show PCDH10 ELISA Kits) antagonized MM cell proliferation via the downregulation of Wnt (show WNT2 ELISA Kits)/beta-catenin (show CTNNB1 ELISA Kits)/BCL-9 (show BCL9 ELISA Kits) signaling, whereas PCDH10 (show PCDH10 ELISA Kits) repressed the expression of AKT (show AKT1 ELISA Kits) to promote the expression of GSK3beta and then to restrain the activation of beta-catenin (show CTNNB1 ELISA Kits)

  5. The inhibition of the transcriptional activity of BCL9-2 by WWOX (show WWOX ELISA Kits) and HDAC3 (show HDAC3 ELISA Kits) constitutes a new molecular mechanism and provides new insight for a broad range of cancers.

  6. BCL9-2 induces ER positive breast cancers in vivo, regulates ER expression by a novel ss-catenin independent mechanism in breast cancer cells.

  7. By beta-catenin's association with LEF1 (show LEF1 ELISA Kits) and BCL9-2/B9L.

  8. MiR (show MLXIP ELISA Kits)-30-5p downregulation occurs as a result of interaction between multiple myeloma cells and bone marrow stromal cells, which in turn enhances expression of BCL9 (show BCL9 ELISA Kits).

  9. we detected five SNPs in the first two genes/loci - BCL9 and C9orf5 - strongly associated with negative symptoms of schizophrenia

  10. Inhibition of the BCL9 (show BCL9 ELISA Kits)-beta-catenin (show CTNNB1 ELISA Kits) interaction and selectively suppresses oncogenic Wnt (show WNT2 ELISA Kits) transcription.

B-Cell CLL/lymphoma 9-Like (BCL9L) Antigen Profile

Antigen Summary

BCL9 is associated with B-cell acute lymphoblastic leukemia. It may be a target of translocation in B-cell malignancies with abnormalities of 1q21. Its function is unknown. The overexpression of BCL9 may be of pathogenic significance in B-cell malignancies.

Gene names and symbols associated with BCL9L

  • B-cell CLL/lymphoma 9-like (BCL9L) antibody
  • B cell CLL/lymphoma 9 (Bcl9) antibody
  • B cell CLL/lymphoma 9-like (Bcl9l) antibody
  • B-cell CLL/lymphoma 9 (BCL9) antibody
  • B-cell CLL/lymphoma 9-like (Bcl9l) antibody
  • B-cell CLL/lymphoma 9-like (bcl9l) antibody
  • 2610202E01Rik antibody
  • 8030475K17Rik antibody
  • A330041G23Rik antibody
  • B9L antibody
  • BC003321 antibody
  • bcl9-2 antibody
  • BCL9L antibody
  • DLNB11 antibody
  • Gm130 antibody
  • LGS antibody

Protein level used designations for BCL9L

B-cell CLL/lymphoma 9-like , b-cell CLL/lymphoma 9-like protein-like , B-cell CLL/lymphoma 9 protein , B-cell lymphoma 9 protein , bcl-9 , nuclear co-factor of beta-catenin signalling , B-cell CLL/lymphoma 9-like protein , B-cell lymphoma 9-like protein , BCL9-like protein , BCL9-related beta-catenin-binding protein , protein BCL9-2 , protein legless homolog

419785 Gallus gallus
451596 Pan troglodytes
489377 Canis lupus familiaris
539340 Bos taurus
100063146 Equus caballus
100444640 Pongo abelii
100515846 Sus scrofa
77578 Mus musculus
80288 Mus musculus
607 Homo sapiens
100155378 Sus scrofa
283149 Homo sapiens
300673 Rattus norvegicus
449532 Danio rerio
Selected quality suppliers for B-Cell CLL/lymphoma 9-Like (BCL9L) ELISA Kits
Did you look for something else?